PTC Inc.
NASDAQ Global SelectRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- PTC Inc. (NASDAQ: PTC) develops and delivers software solutions that enable discrete manufacturers to design, operate, and service complex products across the product lifecycle; its core offerings include Creo for parametric 3D CAD design and simulation, Windchill for product lifecycle management (PLM), Codebeamer for application lifecycle management (ALM), Mathcad for engineering calculations, Vuforia for augmented reality (AR), ServiceMax for field service management, Arbortext for dynamic publishing, and Onshape for cloud-native CAD and product data management. The company serves industries such as aerospace and defense, automotive, electronics, high-tech, industrial equipment, and retail with subscription-based SaaS models emphasizing AI integration, digital transformation, and intelligent product lifecycle management. Founded in 1985 and headquartered in Boston, Massachusetts, PTC operates globally with approximately 7,500 employees. PTC continues its strategic shift toward SaaS and AI-driven solutions, including the divestiture of its Kepware industrial connectivity and ThingWorx IoT businesses announced in late 2025 to sharpen focus on the Intelligent Product Lifecycle vision. In April 2025, the company acquired IncQuery Group to bolster ALM and systems engineering capabilities, following the 2022 acquisition of Intland Software for Codebeamer and the 2019 purchase of Onshape. Recent expansions include deepened partnerships such as with Garrett Motion in November 2025 for Codebeamer+ ALM and Windchill+ PLM adoption, and with NVIDIA for AI enhancements, alongside launches like Arena PLM AI Assistant and Creo AI Advisor for real-time design guidance.
PTC Therapeutics Expands Rare Disease Portfolio with 'Unique Opportunity'
PTC Advances Leadership in AI-Driven Design with Launch of Onshape FeatureScript MCP Server
PTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program
PTC Inc. (NASDAQ:PTC) Receives Average Recommendation of “Hold” from Brokerages
Bank of America Corp DE Sells 39,720 Shares of PTC Inc. $PTC
Is It Too Late to Buy PTC Inc (PTC) After 5.9% Rally? GF Value Says Undervalued
PTC Strengthens ALM Portfolio with New AI and Configuration Management Capabilities for Enterprise Complexity
PTC Will Participate in Upcoming Investor Conferences
PTC Launches Arena Connect to Simplify Enterprise Integrations for Manufacturers
PTC Rides AI, Cloud and Product Data Trends Across Industrial Markets
PTC's AI-Led Lifecycle Strategy Reshapes Its Long-Term Growth Outlook
Is PTC Stock Attractive After Its Sharp Pullback and Mixed Earnings?
Arrowstreet Capital Limited Partnership Cuts Position in PTC Inc. $PTC
PTC Inc. $PTC Shares Purchased by Amundi
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
PTC Q3 Earnings & Sales Lag, ARR View Raised on AI Momentum & Buybacks
PTC Inc (PTC) (Q3 2026) Earnings Call Highlights: Strong ARR Growth and Raised Guidance Signal Accelerating Momentum
PTC Inc. (PTC) Q3 2026 Earnings Call Transcript
PTC Q3 Earnings Call Highlights
PTC Inc. (PTC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates